Journal
MOLECULAR NEUROBIOLOGY
Volume 56, Issue 1, Pages 490-501Publisher
SPRINGER
DOI: 10.1007/s12035-018-1096-7
Keywords
Chronic mild stress; Antidepressants; Indoleamine 2; 3-dioxygenase; Kynurenine pathways; Glutamate neurotransmission; Frontal cortex
Categories
Funding
- Instituto de Salud Carlos III [PI13/01102]
- Fondos Europeos de Desarrollo Regional (FEDER)
- Ministerio de Economia, Industria y Competitividad (MINECO) [SAF2016-75500-R]
- CIBERSAM [SAM15PINT1514]
- CONACYT (Consejo Nacional de Ciencia y Tecnologia, Mexico)
Ask authors/readers for more resources
Immune stimulation might be involved in the pathophysiology of major depressive disorder (MDD). This stimulation induces indoleamine 2,3-dioxygenase (IDO), an enzyme that reduces the tryptophan bioavailability to synthesize serotonin. IDO products, kynurenine metabolites, exert neurotoxic/neuroprotective actions through glutamate receptors. Thus, we study elements of these pathways linked to kynurenine metabolite activity examining whether antidepressants (ADs) can modulate them. Male Wistar rats were exposed to chronic mild stress (CMS), and some of them were treated with ADs. The expression of elements of the IDO pathway, including kynurenine metabolites, and their possible modulation by ADs was studied in the frontal cortex (FC). CMS increased IDO expression in FC compared to control group, and ADs restored the IDO expression levels to control values. CMS-induced IDO expression led to increased levels of the excitotoxic quinolinic acid (QUINA) compared to control, and ADs prevented the rise in such levels. Neither CMS nor ADs changed significantly the antiexcitotoxic kynurenic acid (KYNA) levels. The QUINA/KYNA ratio, calculated as excitotoxicity risk indicator, increased after CMS and ADs prevented this increase. CMS lowered excitatory amino acid transporter (EAAT)-1 and EAAT-4 expression, and some ADs restored their expression levels. Furthermore, CMS decreased N-methyl-D-aspartate receptor (NMDAR)-2A and 2B protein expression, and ADs mitigated this decrease. Our research examines the link between CMS-induced pro-inflammatory cytokines and the kynurenine pathway; it shows that CMS alters the kynurenine pathway in rat FC. Importantly, it also reveals the ability of classic ADs to prevent potentially harmful situations related to the brain scenario caused by CMS.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available